Nucleic Acid Isolation and Purification

Nucleic Acid Isolation and Purification

Global Nucleic Acid Isolation and Purification Market to Reach US$12.0 Billion by 2030

The global market for Nucleic Acid Isolation and Purification estimated at US$7.6 Billion in the year 2023, is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Nucleic Acid Isolation and Purification Instruments segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 9.8% CAGR

The Nucleic Acid Isolation and Purification market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Nucleic Acid Isolation and Purification Market – Key Trends & Drivers Summarized

Why Is Nucleic Acid Isolation and Purification Critical in Biotechnology?
Nucleic acid isolation and purification is a fundamental process in molecular biology, enabling the extraction of DNA and RNA from biological samples for use in various downstream applications such as genomics, diagnostics, and drug development. This process ensures that high-quality nucleic acids are obtained, free from contaminants, which is critical for the accuracy of techniques like PCR, sequencing, and gene editing. The growing adoption of precision medicine and personalized therapies has amplified the need for efficient and reliable nucleic acid purification technologies, as these methods form the backbone of diagnostic assays and therapeutic interventions in cancer, infectious diseases, and genetic disorders.

How Are Technological Advancements Shaping Nucleic Acid Isolation and Purification?
Technological innovations have significantly impacted the nucleic acid isolation and purification market, enhancing the efficiency, speed, and scalability of these processes. Automated nucleic acid extraction systems have emerged as vital tools in research laboratories and clinical diagnostics, reducing manual errors and increasing throughput. Furthermore, advancements in magnetic bead-based purification and microfluidics are enabling faster and more efficient sample processing with minimal reagent use. These technologies are especially important in high-demand environments, such as COVID-19 testing labs, where rapid and accurate nucleic acid extraction is critical for large-scale testing. As next-generation sequencing (NGS) continues to grow, more advanced nucleic acid isolation techniques are being developed to ensure high-purity samples for genomic research.

What Impact Does the Rise of Genomics and Personalized Medicine Have on Nucleic Acid Purification?
The rise of genomics and personalized medicine is a major driver in the nucleic acid isolation and purification market. With healthcare shifting towards more tailored treatments based on individual genetic profiles, there is an increasing need for reliable methods to extract and purify nucleic acids from various biological samples. Precision medicine relies heavily on genomic data to diagnose and treat diseases such as cancer and inherited disorders, creating a demand for advanced purification technologies that can process large volumes of samples with high accuracy. Additionally, the growing field of liquid biopsy, which involves the analysis of circulating tumor DNA (ctDNA) and RNA, is further expanding the market for highly sensitive nucleic acid purification techniques.

Growth in the Nucleic Acid Isolation and Purification Market Is Driven by Several Factors
The growth in the nucleic acid isolation and purification market is driven by several factors, including the rising demand for molecular diagnostics, advancements in genomics research, and the increasing application of personalized medicine. The need for rapid and accurate diagnostics, particularly in infectious disease testing, has accelerated the adoption of automated and high-throughput nucleic acid extraction systems. Furthermore, the expansion of genomic sequencing and gene therapy research is driving demand for more efficient, scalable nucleic acid purification methods. The increasing prevalence of cancer and genetic disorders, along with the shift toward precision medicine, is creating significant opportunities for companies specializing in nucleic acid isolation technologies. Regulatory support and government funding for genomics and diagnostic research are also key contributors to the market`s growth.

Select Competitors (Total 18 Featured) -

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• GE Healthcare
• Illumina, Inc.
• Merck KgaA
• New England Biolabs, Inc.
• Promega Corporation
• Qiagen NV
• Roche Molecular Systems, Inc.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.